Ingredients | Amount Per Serving |
---|---|
( calamus )
(root)
(1:5)
|
0.13 mL |
Glycerin, Chocolate flavor
Below is general information about the effectiveness of the known ingredients contained in the product Calamus Root Chocolate Flavor. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Although there has been interest in using oral calamus for anorexia nervosa, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for asthma, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for bronchitis, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for cancer, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for colic, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for depression, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for diabetes, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for diarrhea, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for dyspepsia, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for flatulence, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for gastritis, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for headache, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using topical calamus for hemorrhoids, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for memory, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for obesity, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for peptic ulcers, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for rheumatoid arthritis, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for seizures, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for stroke, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using topical calamus for tinnitus, there is insufficient reliable information about the clinical effects of calamus for this condition.
Although there has been interest in using oral calamus for toothache, there is insufficient reliable information about the clinical effects of calamus for this condition. More evidence is needed to rate calamus for these uses.
Below is general information about the safety of the known ingredients contained in the product Calamus Root Chocolate Flavor. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
LIKELY UNSAFE ...when used orally. The FDA prohibits calamus use in food products due to evidence of carcinogenic effects in animals receiving high doses of a calamus strain high in beta-asarone (93978,94727,94728). However, the beta-asarone content can vary widely among species from 0% to 96% (6); some products may be safer than others. There is insufficient reliable information available about the safety of calamus when used topically.
PREGNANCY AND LACTATION: LIKELY UNSAFE
when used orally; avoid using (4,500).
Below is general information about the interactions of the known ingredients contained in the product Calamus Root Chocolate Flavor. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Theoretically, taking calamus might reduce the effectiveness of antacids.
Details
Some research suggests that calamus lowers gastric pH (19).
|
Theoretically, concurrent use of anticholinergic drugs and calamus might decrease the effectiveness of the anticholinergic drug.
Details
In vitro evidence shows that calamus can inhibit acetylcholinesterase (AChE) (38418).
|
Theoretically, taking calamus with other antihypertensive medications might increase the risk of hypotension.
Details
Animal research shows that calamus decreases the rate and strength of the heartbeat, which might lower blood pressure (38444). use with caution.
|
Theoretically, concurrent use of cholinergic drugs and calamus might have an additive effect and increase the risk of cholinergic effects.
Details
In vitro evidence shows that calamus can inhibit acetylcholinesterase (AChE) (38418).
|
Theoretically, concurrent use of CNS depressants and calamus might have an additive effect and increase the risk of sedative effects.
Details
|
Theoretically, taking calamus with drugs metabolized by CYP2D6 might increase drug levels and potentially increase the risk of adverse effects.
Details
In vitro research shows that calamus extract inhibits CYP2D6 enzyme (93975).
|
Theoretically, taking calamus with drugs metabolized by CYP3A4 might increase drug levels and potentially increase the risk of adverse effects.
Details
In vitro research shows that calamus extract inhibits CYP3A4 enzyme (93975).
|
Theoretically, taking calamus might reduce the effectiveness of H2-blockers.
Details
Some research suggests that calamus lowers gastric pH (19).
|
Theoretically, calamus might potentiate the effects and adverse effects of MAOIs.
Details
Some reports suggest that calamus increases the effects of MAOIs (4).
|
Theoretically, taking calamus might reduce the effectiveness of PPIs.
Details
Some research suggests that calamus lowers gastric pH (19).
|
Below is general information about the adverse effects of the known ingredients contained in the product Calamus Root Chocolate Flavor. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General
...There is currently a limited amount of information on the adverse effects of calamus.
Calamus is likely unsafe for use because it may cause cancer.
Most Common Adverse Effects:
Orally: Nausea, vomiting.
Serious Adverse Effects (Rare):
Orally: Cancer, intestinal paralysis.
Orally, nausea, vomiting, and intestinal paralysis have been reported with calamus use (33310,38458,93980). Tachycardia has also been reported (93980).
Cardiovascular ...Tachycardia has been reported as a toxic effect related to oral use of calamus oil (93980).
Gastrointestinal ...A case of gastrointestinal toxicity has been reported in a 19-year-old male who appeared to use calamus root for its euphoric effects. The man ingested a large amount of the root with water and later presented at the emergency department with continuous vomiting, paleness, and sweating. He was treated intravenously with saline and promethazine (38458). Both nausea and vomiting have been reported in patients using calamus oil orally (93980). Intestinal paralysis has also been reported with calamus use in children (33310).
Oncologic ...Beta-asarone, a constituent of calamus, increases the risk of cancer (93978,94727,94728).